OTC Markets OTCPK - Delayed Quote USD
Mosaic ImmunoEngineering, Inc. (CPMV)
0.5400
+0.0283
+(5.53%)
At close: May 13 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Steven W. King | Chairman of the Board, President & CEO | 250k | -- | 1964 |
| Mr. Paul J. Lytle CPA | Executive VP, CFO, Secretary & Director | 116.85k | -- | 1968 |
| Mr. Joseph S. Shan M.P.H. | Head of Clinical Operations | -- | -- | 1973 |
| Dr. Marvin R. Garovoy M.D. | Head of Medical Immuno-Oncology | -- | -- | 1944 |
| Cyril Empig Ph.D. | Head of Vaccine Development | -- | -- | -- |
Mosaic ImmunoEngineering, Inc.
9114 Adams Avenue
Suite 202
Huntington Beach, CA 92646
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Corporate Governance
Mosaic ImmunoEngineering, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 15, 2025 at 10:59 AM UTC - May 22, 2025 at 12:00 PM UTC
Mosaic ImmunoEngineering, Inc. Earnings Date
Recent Events
Related Tickers
9U90.F Unity Biotechnology, Inc.
0.7940
0.00%
9U90.DU Unity Biotechnology Inc
0.7900
+1.28%
OTLC Oncotelic Therapeutics, Inc.
0.0600
+2.21%
LIPO Lipella Pharmaceuticals Inc.
2.3950
-0.21%
SEPN Septerna, Inc.
6.73
-3.58%
AARD Aardvark Therapeutics, Inc.
10.14
-7.57%
TECX Tectonic Therapeutic, Inc.
20.19
-2.51%
NRIX Nurix Therapeutics, Inc.
9.73
-4.42%
FULC Fulcrum Therapeutics, Inc.
5.79
+1.94%
UBX Unity Biotechnology, Inc.
0.8100
-10.21%